Pyxus inks agreement with Turning Point to initiate PMTA submission
Category: #business  By Mateen Dalal  Date: 2020-02-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

Pyxus inks agreement with Turning Point to initiate PMTA submission

Pyxus International, Inc., one of the leading value-added agricultural companies in the world, has reportedly collaborated with Turning Point Brands, a leading company in OTP (Other Tobacco Products) and adult consumer alternatives.

Sources cite that the two companies have agreed to share certain testing data and science-based research to form the foundation of some of their respective PMTAs (Premarket Tobacco Product Applications) before being submitted to U.S. FDA (Food and Drug Administration).

According to reports, Turning Point Brands has inked a supply agreement for its house brands of e-liquids, thereby extending its existing collaboration with Pyxus' joint venture, Purilum, LLC, a manufacturer of high-quality e-liquids, finished bottles, and flavor concentrates products.

Apparently, all tobacco products modified or introduced after Feb. 15, 2007, require premarket permission by the FDA to be commercially marketed in the US. Pursuant to the FDA guidance, all PMTAs are due by 12 May 2020.

Reportedly, both companies will share several costs and key data related to extensive studies conducted to support their PMTAs filings. Additionally, Purilum presently offers the flavor formulations for a few of TPB's innovative products.

Pieter Sikkel, President, CEO and Chairman of Pyxus, said that the company needs likeminded, reputable partners to meet the stringent requirements of the U.S. FDA.

He added that Turning Point Brands, which presently has a strong relationship with the company’s joint venture Purilum, has constantly shown their commitment to quality and compliance. The company is pleased to partner with them to benefit respective PMTAs.

Graham Purdy, COO of Turning Point Brands, said that Purilum has garnered a reputation for excellence in e-liquid production and flavor formulation. Moreover, the consistency and quality of their products are exemplary, and the company is excited to continue to work with them over the next decades.

Both Turning Point Brands and Pyxus anticipate the filing of their respective PMTAs before the May filing deadline.

Source Credit - https://www.prnewswire.com/news-releases/pyxus-signs-agreement-with-turning-point-brands-initiating-pmta-project-collaboration-300999171.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

NHS requests urgent donations of blood plasma from COVID-19 survivors
NHS requests urgent donations of blood plasma from COVID-19 survivors
By Mateen Dalal

According to reliable sources, United Kingdom National Health Service (NHS) has filed an appeal to the individuals recuperated from novel coronavirus to donate blood plasma. The organization apparently intends to treat the people who get infected dur...

OSE Immunotherapeutics receives $228,000 to develop COVID-19 vaccine
OSE Immunotherapeutics receives $228,000 to develop COVID-19 vaccine
By Mateen Dalal

The novel coronavirus outbreak has turned out to be one of the worst disasters the world has witnessed in recent times. At times like this, pharmaceutical companies worldwide have been putting their best foot forward to find the vaccine for COVID-19....

Singapore’s ESR and Sabana REIT propose merger amid pandemic
Singapore’s ESR and Sabana REIT propose merger amid pandemic
By Mateen Dalal

Although the economic impact of the ongoing COVID-19 has significantly impacted prospects for Singapores REITs (Real Estate Investment Trusts), it seems that some resilient spots in the real estate sector will remain where they were. In the latest st...